RNACure Biopharma Company
RNACure Biopharma is partnering with Fudan University and Shanghai JiaoTong University to develop a COVID-19 vaccine. Researchers have placed the most emphasis on formulating mRNAs that can instruct the host to produce virus-like particles (VLPs) with morphological and structural features similar to those of native COVID-19 viruses and activate immune responses.
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
China
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership